Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 8
2005 6
2006 5
2007 2
2009 3
2010 2
2012 1
2013 2
2014 3
2015 1
2016 1
2017 1
2018 2
2019 2
2020 6
2021 6
2022 10
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Miniaturized single-cell technologies for monoclonal antibody discovery.
Van Lent J, Breukers J, Ven K, Ampofo L, Horta S, Pollet F, Imbrechts M, Geukens N, Vanhoorelbeke K, Declerck P, Lammertyn J. Van Lent J, et al. Among authors: geukens n. Lab Chip. 2021 Sep 28;21(19):3627-3654. doi: 10.1039/d1lc00243k. Lab Chip. 2021. PMID: 34505611 Review.
Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium.
Callaway HM, Hastie KM, Schendel SL, Li H, Yu X, Shek J, Buck T, Hui S, Bedinger D, Troup C, Dennison SM, Li K, Alpert MD, Bailey CC, Benzeno S, Bonnevier JL, Chen JQ, Chen C, Cho H, Crompton PD, Dussupt V, Entzminger KC, Ezzyat Y, Fleming JK, Geukens N, Gilbert AE, Guan Y, Han X, Harvey CJ, Hatler JM, Howie B, Hu C, Huang A, Imbrechts M, Jin A, Kamachi N, Keitany G, Klinger M, Kolls JK, Krebs SJ, Li T, Luo F, Maruyama T, Meehl MA, Mendez-Rivera L, Musa A, Okumura CJ, Rubin BER, Sato AK, Shen M, Singh A, Song S, Tan J, Trimarchi JM, Upadhyay DP, Wang Y, Yu L, Yuan TZ, Yusko E, Peters B, Tomaras G, Saphire EO. Callaway HM, et al. Among authors: geukens n. Cell Rep. 2023 Jan 31;42(1):112014. doi: 10.1016/j.celrep.2023.112014. Epub 2023 Jan 12. Cell Rep. 2023. PMID: 36681898 Free PMC article.
Complementarity determining regions in SARS-CoV-2 hybrid immunity.
Frans G, Dillaerts D, Dehaemers T, Van Elslande J, De Leeuw J, Boon L, Maes W, Callewaert N, Calcoen B, Ancheva L, Cockx M, Geukens N, Arat K, Derua R, Vermeersch P, Carpentier SC, Bossuyt X. Frans G, et al. Among authors: geukens n. Front Immunol. 2023 Feb 21;14:1050037. doi: 10.3389/fimmu.2023.1050037. eCollection 2023. Front Immunol. 2023. PMID: 36895570 Free PMC article.
The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?
Fichou Y, Al-Hilaly YK, Devred F, Smet-Nocca C, Tsvetkov PO, Verelst J, Winderickx J, Geukens N, Vanmechelen E, Perrotin A, Serpell L, Hanseeuw BJ, Medina M, Buée L, Landrieu I. Fichou Y, et al. Among authors: geukens n. Acta Neuropathol Commun. 2019 Mar 1;7(1):31. doi: 10.1186/s40478-019-0682-x. Acta Neuropathol Commun. 2019. PMID: 30823892 Free PMC article. Review.
Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13).
Bossuyt X, Vulsteke JB, Van Elslande J, Boon L, Wuyts G, Willebrords S, Frans G, Geukens N, Carpentier S, Tejpar S, Wildiers H, Blockmans D, De Langhe E, Vermeersch P, Derua R. Bossuyt X, et al. Among authors: geukens n. Autoimmun Rev. 2023 Apr;22(4):103288. doi: 10.1016/j.autrev.2023.103288. Epub 2023 Feb 2. Autoimmun Rev. 2023. PMID: 36738952 Free PMC article.
Type I signal peptidases of Gram-positive bacteria.
van Roosmalen ML, Geukens N, Jongbloed JD, Tjalsma H, Dubois JY, Bron S, van Dijl JM, Anné J. van Roosmalen ML, et al. Among authors: geukens n. Biochim Biophys Acta. 2004 Nov 11;1694(1-3):279-97. doi: 10.1016/j.bbamcr.2004.05.006. Biochim Biophys Acta. 2004. PMID: 15546672 Free article. Review.
Combined deficient response to polysaccharide-based and protein-based vaccines predicts a severe clinical phenotype.
Cockx M, Haerynck F, Hoste L, Schrijvers R, Van der Werff Ten Bosch J, Dillaerts D, Thomas D, Schaballie H, Bucciol G, Robberechts W, Patel D, Berbers G, Desombere I, Geukens N, Meyts I, Bossuyt X. Cockx M, et al. Among authors: geukens n. Clin Chem Lab Med. 2023 Sep 21;62(1):138-149. doi: 10.1515/cclm-2023-0626. Print 2024 Jan 26. Clin Chem Lab Med. 2023. PMID: 37731388
68 results